University of Texas-Health Science Center At San Antonio: FDA Approves New MPN Drug That Mays Cancer Center Director Helped Develop
September 10, 2019
September 10, 2019
SAN ANTONIO, Texas, Sept. 10 [TNSmedicalresearch] -- The University of Texas Health Science Center at San Antonio issued the following news release:
September is Blood Cancer Awareness Month, and this year patients with myelofibrosis, a rare blood cancer, have reason to celebrate. In mid-August, the U.S. Food and Drug Administration approved the first new medication in nearly a decade for patients with myelofibrosis.
Ruben Mesa, M.D., FACP, was part of the international . . .
September is Blood Cancer Awareness Month, and this year patients with myelofibrosis, a rare blood cancer, have reason to celebrate. In mid-August, the U.S. Food and Drug Administration approved the first new medication in nearly a decade for patients with myelofibrosis.
Ruben Mesa, M.D., FACP, was part of the international . . .